Purdue Pharma & OxyContin: Regulatory Gamesmanship? A Debate
Recently, the FDA declared that it was no longer accepting applications for generic formulations of Oxycontin. The reason? Because Purdue Pharma, OxyContin’s manufacturer, had developed–and received...
View ArticlePodcast No. 8
Hey, CLB Podcast listeners–we’ve got No. 8 for you. This month, we feature Hank Greely with… Fellow Jake Sherkow on the Indian Supreme Court Gleevec decision; Fellow Matt Lamkin on disability law and...
View ArticleMaryland v. King: A Mouthful of Contradictions
The Supreme Court’s opinion in Maryland v. King came out earlier today, concerning whether the Fourth Amendment permits the collection of DNA samples upon arrest. In an interesting 5-4 split (with...
View ArticlePodcast No. 9
Hey, CLB Podcast listeners–we’ve got No. 9 for you. This month, we feature Hank Greely with… Fellow Jake Sherkow on Bowman v. Monsanto, the patented soybean seed case; Hank with soon-to-be former...
View ArticleMaryland (v. King) Corrections Department: David Kaye on Bertillonage
In a recent post on the Maryland v. King case, I criticized the Court’s reference to Bertillon measurements, or Bertillonage, as “a thoroughly debunked form of proto-eugenics.” In correspondance,...
View ArticleMyriad: Some Initial Thoughts
It has been a busy day digesting and commenting on the Myriad decision. As part of a collaborative effort with Stanford’s Medical School, I posted some initial thoughts on the case on Scope that we’re...
View ArticleVIDEO: De-Extinction: Ethics, Law & Politics
We’ve recently posted video from our conference, held on May 31st, on, De-Extinction: Ethics, Law & Politics. You can check out those videos on our YouTube channel, here–or watch the individual...
View ArticleCLB Podcast! August 2013
Hey CLB Podcast listeners: we’ve got our new podcast up for August 2013. In this edition, we welcome our new fellow, Patti Zettler, discuss whether blood is “property” for purposes of the federal...
View ArticleSupreme Court Bioscience Wrap-Up Podcast
Hey CLB Podcast listeners: we’ve yet another podcast up for August 2013. Here, Hank and I wrap-up the five bioscience cases from the past Supreme Court term: Bowman v. Monsanto (seed patenting); Mutual...
View ArticleSCOTUS Bioscience Cert Watch!
OT 2012 in the Supreme Court featured a total of five (maybe, five-and-a-half) bioscience cases: Bowman v. Monsanto (seed patenting); Mutual Pharma v. Bartlett (generic drug tort liability); FTC v....
View Article2014 CLB Workshop Series
Beginning in January, CLB will host its annual Workshop Series. The Workshop brings leading law professors and other academics from throughout the U.S. to present papers of interest to Stanford...
View ArticleThe World vs. Myriad(’s Patents’ Validity)
In the latest salvo in Myriad Genetic’s bloody patent disputes with its BRCA-testing competitors, Myriad has sued LabCorp after the company announced it was to begin offering its own BRCA-testing...
View Article
